These effects on CREB directly contribute to the synaptic and memory impairments seen in AD, and such findings have been validated in human studies, where decreased levels of CREB and phospho-CREB were observed in the hippocampus of AD patients [58]. This evidence concerns the gene CREB1 and Alzheimer disease.